These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. HeartMate® II continuous-flow left ventricular assist system. Sheikh FH; Russell SD Expert Rev Med Devices; 2011 Jan; 8(1):11-21. PubMed ID: 21158536 [TBL] [Abstract][Full Text] [Related]
44. Thromboembolism is linked to intraventricular flow stasis in a patient supported with a left ventricle assist device. May-Newman K; Wong YK; Adamson R; Hoagland P; Vu V; Dembitsky W ASAIO J; 2013; 59(4):452-5. PubMed ID: 23820289 [TBL] [Abstract][Full Text] [Related]
45. Percutaneous treatment of left ventricular assist device outflow graft obstruction. Raza M; Williams N; Barry N; Singh V Catheter Cardiovasc Interv; 2021 Jan; 97(1):152-156. PubMed ID: 32812368 [TBL] [Abstract][Full Text] [Related]
46. Principles of HeartMate II implantation to avoid pump malposition and migration. Adamson RM; Mangi AA; Kormos RL; Farrar DJ; Dembitsky WP J Card Surg; 2015 Mar; 30(3):296-9. PubMed ID: 25472467 [TBL] [Abstract][Full Text] [Related]
47. Implantable ventricular assist device exchange with focused intravascular deairing techniques. Woo YJ; Acker MA Ann Thorac Surg; 2011 Jan; 91(1):306-7. PubMed ID: 21172546 [TBL] [Abstract][Full Text] [Related]
48. Quantitative Assessment of Aortic Hemodynamics for Varying Left Ventricular Assist Device Outflow Graft Angles and Flow Pulsation. Sahni A; McIntyre EE; Pal JD; Mukherjee D Ann Biomed Eng; 2023 Jun; 51(6):1226-1243. PubMed ID: 36705866 [TBL] [Abstract][Full Text] [Related]
49. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure. Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952 [TBL] [Abstract][Full Text] [Related]
50. The pharmacotherapy of the HeartMate II, a continuous flow left ventricular assist device, in patients with advanced heart failure: integration of disease, device, and drug. Jennings DL; Chambers RM; Schillig JM Ann Pharmacother; 2010 Oct; 44(10):1647-50. PubMed ID: 20841512 [TBL] [Abstract][Full Text] [Related]
51. Second harmonic echocardiography and spontaneous contrast during implantation of a left ventricular assist device. Hubbert L; Peterzén B; Ahn H; Janerot-Sjoberg B ASAIO J; 2010; 56(5):417-21. PubMed ID: 20613488 [TBL] [Abstract][Full Text] [Related]
52. VADoscopy: a novel intraoperative technique to evaluate HeartMate II left ventricular assist device inflow obstruction and thrombosis. Cheng A; Swartz MF; Massey HT ASAIO J; 2013; 59(6):671-4. PubMed ID: 24088904 [TBL] [Abstract][Full Text] [Related]
53. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading. Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746 [TBL] [Abstract][Full Text] [Related]
54. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score. Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424 [TBL] [Abstract][Full Text] [Related]
55. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. Slaughter MS; Pagani FD; Rogers JG; Miller LW; Sun B; Russell SD; Starling RC; Chen L; Boyle AJ; Chillcott S; Adamson RM; Blood MS; Camacho MT; Idrissi KA; Petty M; Sobieski M; Wright S; Myers TJ; Farrar DJ; J Heart Lung Transplant; 2010 Apr; 29(4 Suppl):S1-39. PubMed ID: 20181499 [TBL] [Abstract][Full Text] [Related]
56. Percutaneous Intervention for Left Ventricular Assist Device Outflow Obstruction. Barac YD; Alwair H; DeNino WF; Ghadimi K; Patel CB; Zomorodi AR; Long C; Schroder JN; Milano CA; Daneshmand MA Heart Lung Circ; 2020 Mar; 29(3):e25-e27. PubMed ID: 31530478 [TBL] [Abstract][Full Text] [Related]
57. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes. Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733 [TBL] [Abstract][Full Text] [Related]
58. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550 [TBL] [Abstract][Full Text] [Related]